Literature DB >> 15326149

Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy.

Marcus A Bearse1, Ying Han, Marilyn E Schneck, Shirin Barez, Carl Jacobsen, Anthony J Adams.   

Abstract

PURPOSE: To study retinal dysfunction in diabetes and early nonproliferative diabetic retinopathy (NPDR) using a new method to analyze local multifocal electroretinogram oscillatory potentials (mfOPs).
METHODS: One eye of each of 26 normal subjects, 16 diabetic subjects without retinopathy (NoR), and 16 diabetic subjects with early NPDR was examined. Slow-flash multifocal electroretinograms (sf-mfERGs) were recorded from the central 45 degrees, and stereo fundus photographs of the diabetic eyes were taken. The first-order (K1), induced first-order (K1i), and second-order (K2) response components were extracted from each retinal location, and K1i and K2 were added to create Ks2. Responses from 35 contiguous areas were digitally filtered 90 to 225 Hz to isolate the mfOPs. The signal-to-noise ratio (SNR) of the mfOPs was calculated, and abnormality was defined as SNR below the fifth percentile of the normal subjects.
RESULTS: Combining the K1i and K2 components to form Ks2 before isolation of the mfOPs by digital filtering increased the SNR. Mean Ks2 and K1 mfOP SNRs were abnormal in 25% and 19% of the NoR eyes, respectively, and both were abnormal in 62% of the NPDR eyes. The retinal distributions of the local Ks2 and K1 mfOP abnormalities overlapped, but they differed. Furthermore, local Ks2 mfOP abnormalities were preferentially associated with retinal sites containing NPDR but K1 mfOP abnormalities were not.
CONCLUSIONS: The cells that contribute to the generation of local mfOPs are affected by diabetes and, to a greater degree, by early NPDR. The results suggest that fast adaptive mechanisms influencing the mfOPs are most abnormal at retinal sites containing NPDR. Copyright Association for Research in Vision and Ophthalmology

Entities:  

Mesh:

Year:  2004        PMID: 15326149     DOI: 10.1167/iovs.04-0308

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  38 in total

Review 1.  A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Authors:  Marcus A Bearse; Anthony J Adams; Ying Han; Marilyn E Schneck; Jason Ng; Kevin Bronson-Castain; Shirin Barez
Journal:  Prog Retin Eye Res       Date:  2006-09-01       Impact factor: 21.198

2.  Detecting ocular-visual function changes in diabetes.

Authors:  C A Westall
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

3.  Effect of experimental glaucoma in primates on oscillatory potentials of the slow-sequence mfERG.

Authors:  Nalini V Rangaswamy; Wei Zhou; Ronald S Harwerth; Laura J Frishman
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-02       Impact factor: 4.799

4.  Analysis of multifocal electroretinograms from a population with type 1 diabetes using partial least squares reveals spatial and temporal distribution of changes to retinal function.

Authors:  Tom Wright; Filomeno Cortese; Josefin Nilsson; Carol Westall
Journal:  Doc Ophthalmol       Date:  2012-05-20       Impact factor: 2.379

5.  Retinal vasculature-function correlation in non-proliferative diabetic retinopathy.

Authors:  Yunkao Zeng; Dan Cao; Dawei Yang; Xuenan Zhuang; Yunyan Hu; Miao He; Honghua Yu; Jun Wang; Cheng Yang; Liang Zhang
Journal:  Doc Ophthalmol       Date:  2019-09-24       Impact factor: 2.379

6.  Multifocal ERG defects associated with insufficient long-term glycemic control in adolescents with type 1 diabetes.

Authors:  Ekta Lakhani; Tom Wright; Mohamed Abdolell; Carol Westall
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

Review 7.  Multifocal electroretinography in diabetic retinopathy and diabetic macular edema.

Authors:  Marcus A Bearse; Glen Y Ozawa
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

8.  Correlation between diabetic lower-extremity arterial disease and diabetic neuropathy in patients with type II diabetes: an exploratory study.

Authors:  Peng Sun; Jianchao Guo; Na Xu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 9.  Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.

Authors:  S Priya Narayanan; Esraa Shosha; Chithra D Palani
Journal:  Pharmacol Res       Date:  2019-06-15       Impact factor: 7.658

10.  Diabetes changes the levels of ionotropic glutamate receptors in the rat retina.

Authors:  Ana R Santiago; Joana M Gaspar; Filipa I Baptista; Armando J Cristóvão; Paulo F Santos; Willem Kamphuis; António F Ambrósio
Journal:  Mol Vis       Date:  2009-08-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.